Michael S. Lawrence, Ph.D.
This page shows the publications Michael Lawrence has written about Von Hippel-Lindau Tumor Suppressor Protein.
Sporadic hemangioblastomas are characterized by cryptic VHL inactivation. Acta Neuropathol Commun. 2014 Dec 24; 2:167.
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.